封面
市场调查报告书
商品编码
1712617

2025年全球肿瘤消融设备市场报告

Tumor Ablation Therapy Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肿瘤消融设备的市场规模将快速成长。预计到 2029 年将成长至 14.4 亿美元,复合年增长率为 14.8%。预测期内的成长归因于个人化医疗、联合治疗、人工智慧和影像引导消融、远端医疗和远距咨询以及培训和教育。预测期内的关键趋势包括消融技术、影像引导、机器人和导航辅助、免疫肿瘤学整合、经皮消融和影像引导消融的进步。

由于癌症发生率的不断上升,肿瘤消融设备市场正在不断增长。癌症是导致死亡的主要原因,约占全球癌症死亡人数的六分之一。肿瘤消融是一种微创手术,广泛用于治疗各种类型的肿瘤,包括肺癌、肝癌、肾臟癌和骨癌。例如,美国非营利医疗组织美国癌症协会估计,2023 年美国将新增约 1,958,310 例癌症病例,高于 2022 年的 1,918,030 例。这种治疗方法正在支持肿瘤消融设备市场的成长,因为它提供了一种有效的治疗选择,特别是对于对化疗和放射线治疗没有反应的患者。

预计微创手术需求的不断增长将推动肿瘤消融设备市场的发展。微创手术涉及使用特殊工具和技术来最大限度地减少切口,从而减少对患者身体的伤害。肿瘤消融装置在这些手术中发挥关键作用,它可以有效地破坏肿瘤,同时最大限度地减少对周围组织的损害。例如,2023年1月,美国机器人产品製造商Intuitive Surgical Inc.报告称,2022年使用达文西手术系统进行了约187.5万例手术,较2021年的约159.4万例增长18%。因此,微创手术需求的不断增长预计将推动肿瘤消融设备市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤消融设备PESTEL分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 最终用途产业分析
  • 全球肿瘤消融设备市场:成长率分析
  • 全球肿瘤消融设备市场表现:规模与成长,2019-2024
  • 全球肿瘤消融设备市场预测:规模与成长,2024-2029 年,2034 年
  • 肿瘤消融设备的全球总目标市场(TAM)

第六章市场区隔

  • 全球肿瘤消融设备市场(按技术、性能和预测),2019-2024 年、2024-2029 年、2034 年
  • 射频消融术
  • 微波消融
  • 冷冻疗法
  • 不可逆电穿孔消融
  • 其他技术
  • 全球肿瘤消融设备市场按治疗类型、表现和预测,2019-2024 年、2024-2029 年、2034 年
  • 外科手术
  • 腹腔镜检查
  • 经皮
  • 全球肿瘤消融设备市场:按应用、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 肾癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 其他用途
  • 全球肿瘤消融设备市场(按最终用户、性能和预测)2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 肿瘤诊所
  • 其他最终用户
  • 全球肿瘤消融设备市场,射频消融术(RFA) 类型细分,表现和预测,2019-2024 年、2024-2029 年、2034 年
  • 单极射频消融装置
  • 双极射频消融装置
  • 全球肿瘤消融设备市场,依微波消融型细分,绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 高频微波设备
  • 低频微波设备
  • 全球肿瘤消融设备市场冷冻疗法细分市场(按类型、性能和预测),2019-2024 年、2024-2029 年、2034 年
  • 基于液态氮的装置
  • 基于氩气的装置
  • 全球不可逆电穿孔消融 (IRE) 肿瘤消融设备市场区隔(按类型)、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 奈米刀消融系统
  • 高压脉衝发生器
  • 全球肿瘤消融设备市场细分(依其他技术类型、实际及预测),2019-2024 年、2024-2029 年、2034 年
  • 雷射消熔设备
  • 超音波导引高强度聚焦超音波(HIFU)
  • 化学消融技术

第七章 区域和国家分析

  • 全球肿瘤消融设备市场:依地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤消融设备市场:依国家、绩效及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章竞争格局与公司概况

  • 肿瘤消融设备市场:竞争格局
  • 肿瘤消融设备市场:公司简介
    • Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Medtronic plc
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • BVM Medical Limited
  • Erbe Elektromedizin GmbH
  • AtriCure Inc.
  • Theraclion
  • INTIO Inc.
  • BIOTRONIK SE & Co. KG
  • Olympus Corporation
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Insightec Ltd.
  • Terumo Corporation
  • Smith & Nephew plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年肿瘤消融设备市场:提供新机会的国家
  • 2029年肿瘤消融设备市场:细分市场带来新机会
  • 2029年肿瘤消融设备市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32827

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.72 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

The rising demand for minimally invasive procedures is expected to propel the tumor ablation therapy devices market. Minimally invasive procedures involve specialized instruments and technology to minimize incisions, leading to less disruption to the patient's body. Tumor ablation therapy devices play a crucial role in these procedures by effectively destroying tumors while minimizing damage to surrounding tissues. For instance, in January 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, marking an 18% increase from the roughly 1,594,000 procedures conducted in 2021. Therefore, the growing demand for minimally invasive procedures is expected to drive the tumor ablation therapy devices market's growth.

Major companies in the tumor ablation therapy devices market are focusing on technological advancements to improve procedure efficiency, safety, reduce radiation exposure, shorten learning curves, and enhance patient outcomes. For instance, Compal Electronics, a Taiwan-based electronics manufacturing company, introduced AblatePal in April 2023, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, particularly non-resectable liver lesions. It employs electrical resistance to generate heat energy in the targeted tissue, resulting in its eradication. This system has applications in therapeutic medical devices, especially for cancer treatment.

Major companies are committed to developing minimally invasive therapies to gain a competitive edge in the market. Minimally invasive therapy is highly effective for tumor ablation, providing precise treatment with minimal disruption to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation aims to expedite the device's development and regulatory evaluation, potentially ensuring quicker patient access. The Vanquish system employs sterile water's thermal energy for precise cancer tissue treatment through a straightforward transurethral procedure, minimizing the risk of severe side effects associated with alternative prostate cancer therapies.

In August 2022, Imagin Medical, a Canada-based urologic oncology company, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from TROD Medical NV for $2.5 million. This acquisition strengthens Imagin's position as a urologic oncology company and broadens its portfolio in the field of prostate cancer. TROD Medical NV is a Belgium-based medical device company.

Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic PLC, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew PLC, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
  • 2) By Treatment: Surgical; Laparoscopic; Percutaneous
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Oncology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
  • 2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
  • 3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
  • 4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
  • 5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
  • Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Trends And Strategies

4. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Ablation Therapy Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Therapy Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM)

6. Tumor Ablation Therapy Devices Market Segmentation

  • 6.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • Other Technologies
  • 6.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical
  • Laparoscopic
  • Percutaneous
  • 6.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Clinics
  • Other End Users
  • 6.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monopolar RFA Devices
  • Bipolar RFA Devices
  • 6.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-frequency Microwave Devices
  • Low-frequency Microwave Devices
  • 6.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen-based Devices
  • Argon Gas-based Devices
  • 6.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NanoKnife Ablation Systems
  • High-voltage Pulse Generators
  • 6.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Ablation Devices
  • Ultrasound-guided High-intensity Focused Ultrasound (HIFU)
  • Chemical Ablation Techniques

7. Tumor Ablation Therapy Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Therapy Devices Market

  • 8.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Therapy Devices Market

  • 9.1. China Tumor Ablation Therapy Devices Market Overview
  • 9.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Therapy Devices Market

  • 10.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Therapy Devices Market

  • 11.1. Japan Tumor Ablation Therapy Devices Market Overview
  • 11.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Therapy Devices Market

  • 12.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Therapy Devices Market

  • 13.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Therapy Devices Market

  • 14.1. South Korea Tumor Ablation Therapy Devices Market Overview
  • 14.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Therapy Devices Market

  • 15.1. Western Europe Tumor Ablation Therapy Devices Market Overview
  • 15.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Therapy Devices Market

  • 16.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Therapy Devices Market

  • 17.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Therapy Devices Market

  • 18.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Therapy Devices Market

  • 19.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Therapy Devices Market

  • 20.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Therapy Devices Market

  • 21.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
  • 21.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Therapy Devices Market

  • 22.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Therapy Devices Market

  • 23.1. North America Tumor Ablation Therapy Devices Market Overview
  • 23.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Therapy Devices Market

  • 24.1. USA Tumor Ablation Therapy Devices Market Overview
  • 24.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Therapy Devices Market

  • 25.1. Canada Tumor Ablation Therapy Devices Market Overview
  • 25.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Therapy Devices Market

  • 26.1. South America Tumor Ablation Therapy Devices Market Overview
  • 26.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Therapy Devices Market

  • 27.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Therapy Devices Market

  • 28.1. Middle East Tumor Ablation Therapy Devices Market Overview
  • 28.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Therapy Devices Market

  • 29.1. Africa Tumor Ablation Therapy Devices Market Overview
  • 29.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Therapy Devices Market Competitive Landscape
  • 30.2. Tumor Ablation Therapy Devices Market Company Profiles
    • 30.2.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. EDAP TMS S.A.
  • 31.3. NeuWave Medical Inc.
  • 31.4. BVM Medical Limited
  • 31.5. Erbe Elektromedizin GmbH
  • 31.6. AtriCure Inc.
  • 31.7. Theraclion
  • 31.8. INTIO Inc.
  • 31.9. BIOTRONIK SE & Co. KG
  • 31.10. Olympus Corporation
  • 31.11. Stryker Corporation
  • 31.12. Merit Medical Systems Inc.
  • 31.13. Insightec Ltd.
  • 31.14. Terumo Corporation
  • 31.15. Smith & Nephew plc

32. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

34. Recent Developments In The Tumor Ablation Therapy Devices Market

35. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Therapy Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Therapy Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Therapy Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer